Jouko Sandholm

Research Associate, Turku Centre for Biotechnology
Email: jouko.sandholm@abo.fi


Peer-reviewed publications

A1 Journal article (refereed)
Deregulation of ocular nucleotide homeostasis in patients with diabetic retinopathy (2017)
Loukovaara S, Sandholm J, Aalto K, Liukkonen J, Jalkanen S, Yegutkin GG
Journal of Molecular Medicine
View on publisher's site
A1 Journal article (refereed)
Lipid bilayer-gated mesoporous silica nanocarriers for tumor-targeted delivery of zoledronic acid in vivo (2017)
Desai D, Zhang J, Sandholm J, Lehtimäki J, Grönroos T, Tuomela J, Rosenholm JM
Molecular Pharmaceutics
View on publisher's site
A1 Journal article (refereed)
Spheroid culture of LuCaP 136 patient-derived xenograft enables versatile preclinical models of prostate cancer (2016)
Valta MP, Zhao HJ, Saar M, Tuomela J, Nolley R, Linxweiler J, Sandholm J, Lehtimaki J, Harkonen P, Coleman I, Nelson PS, Corey E, Peehl DM
Clinical and Experimental Metastasis
View on publisher's site
A1 Journal article (refereed)
Telomeric G-quadruplex-forming DNA fragments induce TLR9-mediated and LL-37-regulated invasion in breast cancer cells in vitro (2016)
Tuomela JM, Sandholm JA, Kaakinen M, Hayden KL, Haapasaari KM, Jukkola-Vuorinen A, Kauppila JH, Lehenkari PP, Harris KW, Graves DE, Selander KS
Breast Cancer Research and Treatment
View on publisher's site
A1 Journal article (refereed)
Toll-like receptor 9 expression is associated with breast cancer sensitivity to the growth inhibitory effects of bisphosphonates in vitro and in vivo (2016)
Jouko Sandholm, Jaakko Lehtimäki, Tamiko Ishizu, Sadanandan E. Velu,
Jeremy Clark, Pirkko Härkönen, Arja Jukkola-Vuorinen, Aleksi Schrey, Kevin
W. Harris, Johanna M. Tuomela, Katri S. Selander

Oncotarget
View on publisher's site

Last updated on 2019-18-04 at 08:08